DVAX | Dynavax Technologies Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	11.75 - 12.24
52 Week Range	9.74 - 15.01
Beta	1.28
Implied Volatility	31.25%
IV Rank	32.49%
Day's Volume	1,307,380
Average Volume	2,296,778
Shares Outstanding	131,455,000
Market Cap	1,599,807,350
Sector	Healthcare
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2004-02-19

Valuation
Profitability
Growth
Health
P/E Ratio	81.13
Forward P/E Ratio	N/A
EPS	0.15
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	408
Country	USA
Website	DVAX

Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufactures and sells CpG 1018, the adjuvant used in HEPLISAV-B. Dynavax Technologies Corporation has a collaboration agreement with Valneva Scotland Limited; agreement with Serum Institute of India Pvt. Ltd.; and sublicense agreement with Merck, Sharp & Dohme Corp. The company was formerly known as Double Helix Corporation and changed its name to Dynavax Technologies Corporation in September 1996. Dynavax Technologies Corporation was incorporated in 1996 and is headquartered in Emeryville, California.

DVAX's peers: ALKS, AMRX, AQST, AVDL, NBIX, ITCI, DCPH, AMPH, LNTH, ANIP, IRWD, PCRX, COLL, EGRX, EBS, DRRX, KALA, OPTN, ORGO

*Chart delayed

Analyzing fundamentals for DVAX we got that it has average fundamentals where Valuation is considered to be slightly overvalued, Profitability is unacceptably poor, Growth is very good and Health is passable. For more detailed analysis please see DVAX Fundamentals page.

Watching at DVAX technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on DVAX Technicals page.